Page last updated: 2024-10-23

bencyclane and Diabetes Mellitus, Type 2

bencyclane has been researched along with Diabetes Mellitus, Type 2 in 1 studies

Bencyclane: A vasodilator agent found to be effective in a variety of peripheral circulation disorders. It has various other potentially useful pharmacological effects. Its mechanism may involve block of calcium channels.

Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kamchatnov, PR1
Karalkin, AV1
Chugunov, AV1
Kabanov, AA1
Bassé, DA1
Mikhaĭlova, NA1
Umarova, KhIa1
Boĭko, AN1

Trials

1 trial available for bencyclane and Diabetes Mellitus, Type 2

ArticleYear
[Patogenetic therapy of patients with diabetes mellitus type 2 and cerebral vascular insufficiency].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2008, Volume: 108, Issue:3

    Topics: Bencyclane; Calcium Channel Blockers; Cerebrovascular Circulation; Cerebrovascular Disorders; Data I

2008